Form4insider filings, from the source

SEC Form 4 · accession 0001104659-19-012642

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Rong Zhou
Officer — EVP, Production Center
Period of report
Mar 1, 2019
Accepted (ET)
Mar 4, 2019 · 8:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 1, 2019M3,200$20.26A55,230D
Common StockMar 1, 2019S3,200$25.00D52,030D
Common StockF2holding———99,668ISee footnote
Common StockF3holding———5,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F4$20.26Mar 1, 2019M3,200D—Aug 5, 2019Common Stock3,2006,400D

Explanation of responses